Immix Biopharma

(NASDAQ) IMMX

Current Price$8.45

Market Cap$601.56M

Since IPO (2021)+130%

5 YearN/A

1 Year+239%

1 Month-19%

Immix Biopharma Financials at a Glance

Market Cap

$601.56M

Revenue (TTM)

$0.00

Net Income (TTM)

-$34.98M

EPS (TTM)

-$0.92

P/E Ratio

-9.19

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$8.45

Volume

53,637

Open

$8.11

Price

$8.45

Volume

53,637

Open

$8.11

Previous Close

$8.45

Daily Range

$8.10 - $8.63

52-Week Range

$1.94 - $11.61

Estimated Earnings Date

Aug 14, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$8.45

Volume

53,637

Open

$8.11

Previous Close

$8.45

Daily Range

$8.10 - $8.63

52-Week Range

$1.94 - $11.61

Estimated Earnings Date

Aug 14, 2026

IMMX News

No articles available.

IMMX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immix Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ilya Rachman, MD, PhD

Website

www.immixbio.com

Headquarters

Los Angeles, CA 90064, US

IMMX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-74%

Return on Capital

-42%

Return on Assets

-37%

Earnings Yield

-10.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$601.56M

Shares Outstanding

71.19M

Volume

53.64K

Avg. Volume

1.02M

Financials (TTM)

Gross Profit

-$364.50K

Operating Income

-$27.21M

EBITDA

-$29.04M

Operating Cash Flow

-$23.93M

Capital Expenditure

-$732.93K

Free Cash Flow

-$24.66M

Cash & ST Invst.

$100.41M

Total Debt

$1.07M

Immix Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$130.77K

N/A

Gross Margin

0.00%

N/A

Market Cap

$601.56M

N/A

Market Cap/Employee

$33.42M

N/A

Employees

N/A

Net Income

-$10.09M

-122.1%

EBITDA

-$9.96M

-122.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$90.58M

+468.9%

Total Debt

$1.04M

-2.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$912.34K

-7.9%

Short Term Debt

$125.39K

+84.9%

Return on Assets

-36.51%

N/A

Return on Invested Capital

-42.31%

N/A

Free Cash Flow

-$9.86M

-462.5%

Operating Cash Flow

-$9.83M

-483.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZNTLZentalis Pharmaceuticals, Inc.

ZNTLZentalis Pharmaceuticals, Inc.$3.75+6.53%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.96-1.25%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$4.16+2.46%

SRZNSurrozen, Inc.

SRZNSurrozen, Inc.$23.39+0.09%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$3.87+1.84%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.74+2.16%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.80-2.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

Questions About IMMX

What is the current price of Immix Biopharma?

Immix Biopharma is trading at $8.45 per share.

What is the 52-week range for Immix Biopharma?

Over the past 52 weeks, Immix Biopharma has traded between $1.94 and $11.61.

How much debt does Immix Biopharma have?

As of the most recent reporting period, Immix Biopharma reported total debt of $1.04M.

How much cash does Immix Biopharma have on hand?

Immix Biopharma reported $79.25M in cash and cash equivalents in its most recent financial results.

What is Immix Biopharma’s dividend yield?

Immix Biopharma does not currently have a dividend yield.

Immix Biopharma

Immix Biopharma Financials at a Glance

IMMX News

IMMX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immix Biopharma

IMMX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immix Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMMX

What is the current price of Immix Biopharma?

What is the 52-week range for Immix Biopharma?

How much debt does Immix Biopharma have?

How much cash does Immix Biopharma have on hand?

What is Immix Biopharma’s dividend yield?

Premium Investing Services